Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|June 1, 2026
Critical Appraisal: Prognostic versus Predictive Surrogate Markers in OncologyAliyah Pabani, Bishal Gyawali
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Facts and Hopes: Immunocytokines for Cancer ImmunotherapyAliyah Pabani, Justin F Gainor
Medicine|January 14, 2022
Evolution of an invasive ductal carcinoma to a small cell carcinoma of the breast: A case reportMarya Hussain, Marcia Abbott, Ramin Zargham, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Management Strategies for Early-Onset Pulmonary Events Associated with BrigatinibD Ross Camidge, Aliyah Pabani, Ronni M Miller, et al.
JTO Clinical and Research Reports|March 14, 2023
Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in <i>BRAF</i> Mutation-Positive NSCLCAmanda J W Gibson, Aliyah Pabani, Michelle L Dean, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population StudyChloe Ahryung Lim, Sunita Ghosh, Hali Morrison, et al.
BMJ Open|February 6, 2023
Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomesVanessa F Bratti, Brooke E Wilson, Rouhi Fazelzad, et al.
JTO Clinical and Research Reports|December 8, 2021
A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in CanadaAnifat A Elegbede, Amanda J Gibson, Andrea S Fung, et al.
Research Square|May 4, 2026
Etiologies and Outcomes of Acute Respiratory Failure in Patients Treated with Immune Checkpoint InhibitorsRupali Sood, Kevin J Psoter, Aliyah Pabani, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian CohortAmanda J W Gibson, Adrian Box, Winson Y Cheung, et al.
Pageof 4